Role of T cells in severe COVID-19 disease, protection, and long term immunity
-
Published:2023-02-08
Issue:3
Volume:75
Page:295-307
-
ISSN:0093-7711
-
Container-title:Immunogenetics
-
language:en
-
Short-container-title:Immunogenetics
Author:
Hermens Julia Maret, Kesmir CanORCID
Abstract
AbstractInfection with SARS-CoV-2 causes wide range of disease severities from asymptomatic to life-threatening disease. Understanding the contribution of immunological traits in immunity against SARS-CoV-2 and in protection against severe COVID-19 could result in effective measures to prevent development of severe disease. While the role of cytokines and antibodies has been thoroughly studied, this is not the case for T cells. In this review, the association between T cells and COVID-19 disease severity and protection upon reexposure is discussed. While infiltration of overactivated cytotoxic T cells might be harmful in the infected tissue, fast responding T cells are important in the protection against severe COVID-19. This protection could even be viable in the long term as long-living memory T cells seem to be stabilized and mutations do not appear to have a large impact on T cell responses. Thus, after vaccination and infections, memory T cells should be able to help prevent onset of severe disease for most cases. Considering this, it would be useful to add N or M proteins in vaccinations, alongside the S protein which is currently used, as this results in a broader T cell response.
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Immunology
Reference91 articles.
1. Adamo S, Chevrier S, Cervia C, Zurbuchen Y, Raeber ME, Yang L, Sivapatham S, Jacobs A, Baechli E, Rudiger A, Stüssi-Helbling M, Huber LC, Schaer DJ, Bodenmiller B, Boyman O, Nilsson J (2021) Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19. Allergy 76(9):2866–2881. https://doi.org/10.1111/all.14866 2. Adamo S, Michler J, Zurbuchen Y, Cervia C, Taeschler P, Raeber ME, Baghai Sain S, Nilsson J, Moor AE, Boyman O (2022) Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection. Nature 602(7895):148–155. https://doi.org/10.1038/s41586-021-04280-x 3. André S, Picard M, Cezar R, Roux-Dalvai F, Alleaume-Butaux A, Soundaramourty C, Cruz AS, Mendes-Frias A, Gotti C, Leclercq M, Nicolas A, Tauzin A, Carvalho A, Capela C, Pedrosa J, Castro AG, Kundura L, Loubet P, Sotto A, Estaquier J (2022) T cell apoptosis characterizes severe COVID-19 disease. Cell Death Differ. https://doi.org/10.1038/s41418-022-00936-x 4. Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Zaks T (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384(5):403–416. https://doi.org/10.1056/NEJMoa2035389 5. Bergamaschi L, Mescia F, Turner L, Hanson AL, Kotagiri P, Dunmore BJ, Ruffieux H, De Sa A, Huhn O, Morgan MD, Gerber PP, Wills MR, Baker S, Calero-Nieto FJ, Doffinger R, Dougan G, Elmer A, Goodfellow IG, Gupta RK, Smith KGC (2021) Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity 54(6):1257-1275.e8. https://doi.org/10.1016/j.immuni.2021.05.010
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|